Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

GYREGYRE
Showing 8 of 9 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in GYRE THERAPEUTICS INC

Bank of New York Mellon Corp holds 62,750 shares of GYRE (GYRE THERAPEUTICS INC), worth $413,523 as of 2026-Q2. The position was increased (+45.4% shares). GYRE represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$413,523

Current Shares

62,750

Total Value Change

+$256,685

Total Shares Change

+50,243

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
62,750
+45.4%
$413,5230.0%$6.59
32
2026-Q1
Increased
43,144
+4.7%
$300,7140.0%$7.90
25
2025-Q4
Increased
41,203
+68.9%
$290,8940.0%$7.02
35
2025-Q3
Increased
24,398
+1.7%
$182,0090.0%$7.50
16
2025-Q2
Increased
23,989
+45.5%
$176,3190.0%$7.42
21
2025-Q1
Increased
16,492
+18.7%
$127,3190.0%$9.11
18
2024-Q4
Increased
13,896
+11.1%
$168,1410.0%$12.66
17
2024-Q3
Decreased
12,507
-31.5%
$156,8380.0%$12.76
0

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used